Heplisav-B Slide Deck
February 21, 2022
Clinical Trial Image Decks
HBV-10: Heplisav-B versus Engerix-B in Healthy Adults 18-55 Years of Age PDF HBV-10: Heplisav-B versus Engerix-B in Healthy Adults 18-55 Years of Age PPTX
HBV-10: Heplisav-B versus Engerix-B in Healthy Adults 18-55 Years of Age - February 16, 2022
HBV-16: Heplisav-B versus Engerix-B in Healthy Adults 40-70 Years of Age PDF HBV-16: Heplisav-B versus Engerix-B in Healthy Adults 40-70 Years of Age PPTX
HBV-16: Heplisav-B versus Engerix-B in Healthy Adults 40-70 Years of Age - February 16, 2022
HBV-17: Heplisav-B versus Engerix-B in CKD - February 16, 2022
HBV-17 (Diabetes Mellitus Subgroup): Heplisav-B versus Engerix-B in CKD PDF HBV-17 (Diabetes Mellitus Subgroup): Heplisav-B versus Engerix-B in CKD PPTX
HBV-17 (Diabetes Mellitus Subgroup): Heplisav-B versus Engerix-B in CKD - February 16, 2022
HBV-23: Heplisav-B versus Engerix-B in Subpopulations Aged 18-70 PDF HBV-23: Heplisav-B versus Engerix-B in Subpopulations Aged 18-70 PPTX
HBV-23: Heplisav-B versus Engerix-B in Subpopulations Aged 18-70 - February 16, 2022
HBV-23 (Diabetes Mellitus Subgroup) in Persons 60-70 Years of Age PDF HBV-23 (Diabetes Mellitus Subgroup) in Persons 60-70 Years of Age PPTX
HBV-23 (Diabetes Mellitus Subgroup) in Persons 60-70 Years of Age - February 16, 2022